Shaping Supply and Demand: Charting a Course for Innovative Development of the Pharmaceutical Industry in Russia

17 Jun , 08:30–10:00
Business Breakfast
Business breakfast
Congress Centre, zone E, conference hall E12

The availability of innovative medical technologies is essential for improving the quality of medical care and public health indicators. New geopolitical challenges necessitate the need for innovative drug import substitution to maintain access to quality medical care for our citizens. The development of innovative drug provision requires a significant increase in the volume of domestic production, overcoming the pharmaceutical industry's passive approach to innovative development. This can be achieved by shifting the regulatory policy towards stimulating the growth of innovative portfolios and promoting the introduction of domestic innovative drugs to the market. An important stimulus is the creation of mechanisms to swiftly and effectively integrate innovations into practical healthcare. The effective development of the Russian pharmaceutical industry is impossible without strengthening export potential and building long-term international cooperation in friendly pharmaceutical markets. How can we strike a balance between the interests of regulators and pharmaceutical manufacturers in the realm of innovative development? What tools and measures of state support are necessary to help the advancement of cutting-edge medical technologies? Which innovative products and technologies currently serve as the main drivers of medical progress? How can we prioritize which innovations should receive funding in the first place? What are the current methods for integrating innovations into the healthcare system, and what obstacles exist in this process? How can we enhance the effectiveness of financing for innovations? What steps should be taken to build partnerships in friendly pharmaceutical markets? How can we boost the export of Russian pharmaceutical products and medical devices?

Aleksandr Petrov, Head of the Expert Council for Regulating the Circulation of Medicines and Medical Devices, Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection

Aleksandr Apazov,
Sergey Glagolev, Deputy Minister of Health of the Russian Federation
Elena Golukhova, Director, National Medical Research Center for Cardiovascular Surgery A.N. Bakulev of the Ministry of Health of the Russian Federation
Viktor Dmitriev, General Director, Association of Russian Pharmaceutical Manufacturers (ARPM) (online)
Kamila Zarubina, Acting Vice President, Executive Director of the Cluster of Biological and Medical Technologies, Skolkovo Foundation
Vasily Ignatiev, General Director, R-Pharm
Dmitriy Sivokoz, General Director, BIOCAD
Evgeniya Shapiro, Director General, PSK Pharma
Vladimir Shipkov, Executive Director, Association of International Pharmaceutical Manufacturers (AIPM)
Lyudmila Scherbakova, Co-Founder, Chairman of the Board of Directors, Velpharm; Member of BRICS Women’s Business Alliance Russia Chapter

Front row participants
Vadim Kukava, Executive Director, The Association of Pharmaceutical Companies «Innovative Pharma»
Inga Nizharadze, Vice President, Pharmimex